All In Biotech

Drug Trial Radar · NCT04959331

Clinical Effectiveness and Bacteriological Eradication of 4 Short-course Antibiotics for Uncomplicated UTIs in Women.

Clinical Effectiveness and Bacteriological Eradication of Three Different Short-course Antibiotic Regimens and Single-dose Fosfomycin for Uncomplicated Lower Urinary Tract Infections in Adult Women.

Last checked: Nov 19, 2026Latest source record: Sep 8, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 1,000 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

1,000

Actual

Start

Nov 2, 2021

Primary completion

Dec 14, 2024

Study completion Dec 31, 2024

Sponsor

Sponsor type
Academic, hospital or other
Collaborators
Balearic Islands Health Service (Ibsalut); Instituto de Investigación Sanitaria Aragón; Gerencia de Atención Primaria, Madrid
First posted
Jul 13, 2021

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
Female only, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Randomized clinical trial in which women aged 18 or older and with symptoms of uncomplicated lower urinary tract infection and a positive urine dipstick analysis will be randomized to one of the following four groups: 2-day 3 g fosfomycin o.d., 3-day pivmecillinam 400 mg. t.i.d, 5-day nitrofurantoin 100 mg t.i.d. or a single dose of 3 g of fosfomycin. Sample: 1,000 patients. Two co-primary endpoints are considered: clinical effectiveness at day 7 and bacteriological eradication at day 14. Follow-up visits are scheduled at days 7 (phone call), 14 and 28 for assessing evolution. Urine samples will be collected in the three on-site visits and urine cultures performed.

Conditions

  • Urinary Tract Infections

Interventions

  • Fosfomycin Trometamol SaltDrug

    Fosfomycin 3 g 2 sachets, taken orally, once daily for two days

  • NitrofurantoinDrug

    Nitrofurantoin 50 mg pills, taken orally, two pills/8 hours, for five days

  • PivmecillinamDrug

    Pivmecillinam 400 mg pills. taken orally, one pill/8 hours, for three days

  • Fosfomycin Trometamol SaltDrug

    Fosfomycin 3 g one sachet, taken orally, for one day

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Clinical effectiveness.Time frame: Day 7.
  2. Bacteriological eradication.Time frame: Day 14.

Locations

33 sites in 1 country. Site status is shown where the registry gives one.

  • Calatayud Center

    Calatayud, Aragon, Spain

  • Las Fuentes Center

    Zaragoza, Aragon, Spain

  • Arrabal Health Center

    Zaragoza, Aragon, Spain

  • Parque Goya Health Center

    Zaragoza, Aragon, Spain

  • Santa Ponça Health Center

    Calvià, Balearic Islands, Spain

  • Emili Darder Center

    Palma de Mallorca, Balearic Islands, Spain

  • Camp Redó Health Center

    Palma de Mallorca, Balearic Islands, Spain

  • Son Pisà Center

    Palma de Mallorca, Balearic Islands, Spain

  • Son Serra-La Vileta Health Center

    Palma de Mallorca, Balearic Islands, Spain

  • Santa Maria del Camí Center

    Santa Maria del Camí, Balearic Islands, Spain

  • Banyoles Center

    Banyoles, Catalonia, Spain

  • Corbera Center

    Corbera de Llobregat, Catalonia, Spain

  • La Gavarra Health Center

    Cornellà de Llobregat, Catalonia, Spain

  • 17 de Setembre Center

    el Prat de Llobregat, Catalonia, Spain

  • Can Vidalet Center

    Esplugues de Llobregat, Catalonia, Spain

  • Santa Clara Center

    Girona, Catalonia, Spain

  • Florida Center

    L'Hospitalet de Llobregat, Catalonia, Spain

  • Can Serra Center

    L'Hospitalet de Llobregat, Catalonia, Spain

  • Montblanc Center

    Montblanc, Catalonia, Spain

  • Pere Garau Center

    Palma de Mallorca, Catalonia, Spain

  • Molí Nou Center

    Sant Boi de Llobregat, Catalonia, Spain

  • Sant Feliu de Guíxols Center

    Sant Feliu de Guíxols, Catalonia, Spain

  • Sant Just Desvern Center

    Sant Just Desvern, Catalonia, Spain

  • Vila Vella Center

    Sant Vicenç dels Horts, Catalonia, Spain

  • Jaume I Health Center

    Tarragona, Catalonia, Spain

  • El Puerto Center

    Coslada, Madrid, Spain

  • Valleaguado Health Center

    Coslada, Madrid, Spain

  • Los Alpes Health Center

    Madrid, Madrid, Spain

  • Aquitania Health Center

    Madrid, Madrid, Spain

  • Mar Báltico Center

    Madrid, Madrid, Spain

  • Buenos Aires Center

    Madrid, Madrid, Spain

  • San Fernando Health Center

    San Fernando de Henares, Madrid, Spain

  • Villarejo de Salvanés Health Center

    Villarejo de Salvanés, Madrid, Spain

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.